CM
ABMD
Castleark Management’s Abiomed Inc ABMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-52,868
| Closed | -$9.02M | – | 404 |
|
|
2019
Q4 | $9.02M | Sell |
52,868
-6,010
| -10% | -$1.03M | 0.36% | 91 |
|
|
2019
Q3 | $10.5M | Sell |
58,878
-67,442
| -53% | -$12M | 0.43% | 74 |
|
|
2019
Q2 | $32.9M | Buy |
126,320
+31,087
| +33% | +$8.1M | 1.26% | 18 |
|
|
2019
Q1 | $27.2M | Sell |
95,233
-23,216
| -20% | -$6.63M | 1.02% | 25 |
|
|
2018
Q4 | $38.5M | Sell |
118,449
-10,210
| -8% | -$3.32M | 1.64% | 9 |
|
|
2018
Q3 | $57.9M | Sell |
128,659
-30,511
| -19% | -$13.7M | 1.66% | 5 |
|
|
2018
Q2 | $65.1M | Sell |
159,170
-104,054
| -40% | -$42.6M | 2% | 2 |
|
|
2018
Q1 | $76.6M | Sell |
263,224
-16,820
| -6% | -$4.89M | 2.43% | 1 |
|
|
2017
Q4 | $52.5M | Sell |
280,044
-59,917
| -18% | -$11.2M | 1.58% | 6 |
|
|
2017
Q3 | $57.3M | Buy |
339,961
+37,616
| +12% | +$6.34M | 1.8% | 2 |
|
|
2017
Q2 | $43.3M | Buy |
302,345
+78,648
| +35% | +$11.3M | 1.42% | 7 |
|
|
2017
Q1 | $28M | Sell |
223,697
-183,742
| -45% | -$23M | 0.88% | 28 |
|
|
2016
Q4 | $45.9M | Buy |
407,439
+45,012
| +12% | +$5.07M | 1.46% | 8 |
|
|
2016
Q3 | $46.6M | Buy |
362,427
+58,850
| +19% | +$7.57M | 1.41% | 14 |
|
|
2016
Q2 | $33.2M | Buy |
303,577
+236,920
| +355% | +$25.9M | 1.06% | 26 |
|
|
2016
Q1 | $6.32M | Sell |
66,657
-70,679
| -51% | -$6.7M | 0.2% | 136 |
|
|
2015
Q4 | $12.4M | Sell |
137,336
-37,345
| -21% | -$3.37M | 0.37% | 70 |
|
|
2015
Q3 | $16.2M | Sell |
174,681
-59,194
| -25% | -$5.49M | 0.52% | 45 |
|
|
2015
Q2 | $15.4M | Sell |
233,875
-7,375
| -3% | -$485K | 0.41% | 68 |
|
|
2015
Q1 | $17.3M | Buy |
241,250
+37,925
| +19% | +$2.71M | 0.42% | 67 |
|
|
2014
Q4 | $7.74M | Buy |
+203,325
| New | +$7.74M | 0.2% | 137 |
|